Synopsis
0
USDMF
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
JDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
About the Company : Chynops Pharma, a company certified with ISO 9001:2015, is situated in Ahmedabad, India. We specialize in exporting, supplying, and trading a wide range of products, including APIs...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
09 Dec 2024
Reply
06 Sep 2024
Reply
14 Mar 2024
Reply
15 May 2023
Reply
19 Jan 2023
Reply
04 Sep 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
74
PharmaCompass offers a list of Oxethazaine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxethazaine manufacturer or Oxethazaine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxethazaine manufacturer or Oxethazaine supplier.
PharmaCompass also assists you with knowing the Oxethazaine API Price utilized in the formulation of products. Oxethazaine API Price is not always fixed or binding as the Oxethazaine Price is obtained through a variety of data sources. The Oxethazaine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxethazaine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxethazaine, including repackagers and relabelers. The FDA regulates Oxethazaine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxethazaine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxethazaine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxethazaine supplier is an individual or a company that provides Oxethazaine active pharmaceutical ingredient (API) or Oxethazaine finished formulations upon request. The Oxethazaine suppliers may include Oxethazaine API manufacturers, exporters, distributors and traders.
click here to find a list of Oxethazaine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxethazaine Drug Master File in Japan (Oxethazaine JDMF) empowers Oxethazaine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxethazaine JDMF during the approval evaluation for pharmaceutical products. At the time of Oxethazaine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxethazaine suppliers with JDMF on PharmaCompass.
A Oxethazaine written confirmation (Oxethazaine WC) is an official document issued by a regulatory agency to a Oxethazaine manufacturer, verifying that the manufacturing facility of a Oxethazaine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxethazaine APIs or Oxethazaine finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxethazaine WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxethazaine suppliers with Written Confirmation (WC) on PharmaCompass.
Oxethazaine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxethazaine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxethazaine GMP manufacturer or Oxethazaine GMP API supplier for your needs.
A Oxethazaine CoA (Certificate of Analysis) is a formal document that attests to Oxethazaine's compliance with Oxethazaine specifications and serves as a tool for batch-level quality control.
Oxethazaine CoA mostly includes findings from lab analyses of a specific batch. For each Oxethazaine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxethazaine may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxethazaine EP), Oxethazaine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxethazaine USP).
Comment (3)
